Pediatric intestinal failure and vascular access.
Emerging developments in the care of intestinal failure (IF) patients have drastically improved their overall prognosis, with recently reported survival rates over 90%. IF patients remain an extremely complex population who benefit from specialized, multidisciplinary care. Advances in the provision of parenteral and enteral nutrition, progress in the management of IF-associated liver disease with parenteral fish oil and catheter-associated blood stream infection with ethanol lock therapy, and the availability of novel surgical interventions, such as the serial transverse enteroplasty procedure, have made this a dynamic health care field with the promise of ongoing improvements in outcomes for these patients.
Department of Surgery and Center for Advanced Intestinal Failure, Children's Hospital Boston and Harvard Medical School, Fegan 3, 300 Longwood Avenue, Boston, MA 02115, USA. firstname.lastname@example.org
SourceThe Surgical clinics of North America 92:3 2012 Jun pg 729-43, x
Catheterization, Central Venous
Short Bowel Syndrome
Pub Type(s)Journal Article